Pan-tissue mitochondrial phenotyping reveals lower OXPHOS expression and function across cancer types
Abstract Targeting mitochondrial oxidative phosphorylation (OXPHOS) to treat cancer has been hampered due to serious side-effects potentially arising from the inability to discriminate between non-cancerous and cancerous mitochondria. Herein, comprehensive mitochondrial phenotyping was leveraged to...
Main Authors: | Ilya N. Boykov, McLane M. Montgomery, James T. Hagen, Raphael T. Aruleba, Kelsey L. McLaughlin, Hannah S. Coalson, Margaret A. Nelson, Andrea S. Pereyra, Jessica M. Ellis, Tonya N. Zeczycki, Nasreen A. Vohra, Su-Fern Tan, Myles C. Cabot, Kelsey H. Fisher-Wellman |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-10-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-43963-5 |
Similar Items
-
Targeting Mitochondrial OXPHOS and Their Regulatory Signals in Prostate Cancers
by: Chia-Lin Chen, et al.
Published: (2021-12-01) -
Pyruvate and uridine rescue the metabolic profile of OXPHOS dysfunction
by: Isabelle Adant, et al.
Published: (2022-09-01) -
They Have Once Before Lived
by: Michael McLane
Published: (2023-11-01) -
Bacterial muropeptides promote OXPHOS and suppress mitochondrial stress in mammals
by: Dong Tian, et al.
Published: (2024-04-01) -
OXPHOS Organization and Activity in Mitochondria of Plants with Different Life Strategies
by: Irina V. Ukolova, et al.
Published: (2023-10-01)